Dark

Check out our Dark Pool Levels

CHNC
CHINA INFRASTRCTR CONS CP
stock OTC

Inactive

Aug 16, 2023

0.000400USD-8.046%(-0.000035)864,890

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Nov 29, 2021

09:30AM EST via NewMediaWire China Infrastructure Construction Corp (OTC: CHNC) GlobeNewswire Inc

Nov 22, 2021

09:00AM EST CHNC Continues to Position Itself as Colombias GlobeNewswire Inc

Nov 17, 2021

09:30AM EST CHNC Announces New Relationship with a Houston, Texas-based GlobeNewswire Inc

Nov 5, 2021

09:15AM EDT via NewMediaWire -- In CHNCs continuing quest to broaden its horizons while spreading education about medicinal cannabis, a new collaboration has been forged with well renowned Drs. Nada AL-Rubaiee. GlobeNewswire Inc

Oct 25, 2021

09:30AM EDT via NewMediaWire China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces the expansion of its clinical research services to Latin America with a new agreement/alliance with QUIASMO, an IPS medical clinic based in Bogot, Colombia. GlobeNewswire Inc

Oct 22, 2021

01:11PM EDT Cannabis Movers & Shakers: GrowGen, The CanCoin, TXOG, HempFusion, Cannabis Bioscience International Benzinga

Oct 20, 2021

09:30AM EDT via NewMediaWire -- China Infrastructure Construction Corp.(OTC: CHNC) (dba Cannabis Bioscience International Holdings) announces that Elizabeth Hernandez, a member of its board of directors and its Chief Operating Officer, has left the Company (July 28th, 2021) and is no longer serving in these capacities. The Company is not aware of her future plans. GlobeNewswire Inc

Oct 18, 2021

09:00AM EDT CHNC Endeavors in Artificial Intelligence Systems for Its GlobeNewswire Inc

Oct 1, 2021

09:00AM EDT CHNC to Seek Up to $3 Million Funding for Expansion of Existing GlobeNewswire Inc

Sep 22, 2021

09:15AM EDT CHNC's Shareholders Rewarded with Astonishing Investment Return of GlobeNewswire Inc

Sep 10, 2021

09:30AM EDT Digital Content Now Available on Amazon, Walmart, Barnes & Noble, Kobo, Sympla and Many Others GlobeNewswire Inc

Jun 14, 2021

09:30AM EDT CHNC Announces Name Change to Cannabis Bioscience International GlobeNewswire Inc

Mar 17, 2021

09:30AM EDT CHNC: Intensity, Determination and a Magical Unwavering Direction GlobeNewswire Inc

Feb 5, 2021

09:30AM EST CHNC Saga, Metamorphosis, and Transformation GlobeNewswire Inc

Nov 18, 2020

08:25AM EST via NewMediaWire -- CHNC(OTCPK: CHNC) Phytotherapy therapeutic program, comprisedof cannabinoidmolecule formulations, has the advantage of not having adverse effects and was developed to treat each of the three stages of COVID-19; from moderate, to the critical curse, and for the final leg of persistent inflammation, immunosuppression and catabolism syndrome. GlobeNewswire Inc

Oct 28, 2020

08:00AM EDT CHNC Aims to be the Global Leader in Cannabis Clinical Trials GlobeNewswire Inc

Share